Phase-II and III trials

Phase-II Trial Of Bharat Biotech’s Covaxin To Begin In September

New Delhi: Covaxin, the indigenously developed COVID-19 vaccine, has been found to be safe, according to preliminary results of Phase-I…

August 14, 2020